2,4-diaminobutyric acid has been researched along with Neuroblastoma in 2 studies
2,4-diaminobutyric acid: RN given refers to parent cpd without isomeric designation
2,4-diaminobutyric acid : A diamino acid that is butyric acid in which a hydrogen at position 2 and a hydrogen at position 4 are replaced by amino groups.
Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Main, BJ | 1 |
| Rodgers, KJ | 1 |
| Tominaga, M | 1 |
| Iwashita, Y | 1 |
| Ohta, M | 1 |
| Shibata, K | 1 |
| Ishio, T | 1 |
| Ohmori, N | 1 |
| Goto, T | 1 |
| Sato, S | 1 |
| Kitano, S | 1 |
2 other studies available for 2,4-diaminobutyric acid and Neuroblastoma
| Article | Year |
|---|---|
Assessing the Combined Toxicity of BMAA and Its Isomers 2,4-DAB and AEG In Vitro Using Human Neuroblastoma Cells.
Topics: Amino Acids, Diamino; Aminobutyrates; Apoptosis; Caspases; Cathepsins; Cell Line, Transformed; Cell | 2018 |
Antitumor effects of the MIG and IP-10 genes transferred with poly [D,L-2,4-diaminobutyric acid] on murine neuroblastoma.
Topics: Aminobutyrates; Animals; Cell Line, Tumor; Chemokine CXCL10; Chemokine CXCL9; Chemokines, CXC; Femal | 2007 |